Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$0.11+0.00 (+1.81%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cellyan Biotechnology free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -$787.07K, down 257.6% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$787.07K | -257.6% |
| FY2025 | Mar 31, 2025 | $499.30K | – |
| FY2024 | Mar 31, 2024 | -$447.07K | -127.7% |
| FY2023 | Mar 31, 2023 | $1.61M | – |
See a number that looks wrong?